The immune system plays a major role in protecting the body from infections like influenza (the flu). The body can acquire immunity in two different ways: active immunity and passive immunity. Even though both forms help fight off viruses, they work in very different ways and last for different periods of time. The flu is a good example to study because it spreads easily, changes often, and requires both prevention and treatment strategies. By looking at how active and passive immunity work against the flu, it becomes easier to understand how vaccines and antibody treatments protect the body.

Active immunity happens when the body is exposed to a virus or a vaccine and then produces its own immune response. This is most commonly seen with flu vaccines. These vaccines contain either weakened or inactive parts of the virus that trigger the immune system without causing illness. Once inside the body, the immune system recognizes viral proteins like hemagglutinin and begins producing antibodies that can target the virus (Wall et al., 2021). These antibodies are important because they help neutralize the virus if the person is exposed later. In addition, the immune system creates memory B cells and T cells, which allow the body to respond faster and more effectively in the future.

However, flu viruses are constantly changing due to mutations, which is why flu vaccines need to be updated every year. This process, known as antigenic drift, makes it harder for the immune system to recognize new strains of the virus. Researchers are currently working on developing universal flu vaccines that target more stable parts of the virus to provide longer-lasting protection (Zhang et al., 2025). These advancements show how active immunity continues to improve and remains one of the most important ways to prevent flu infections.

Passive immunity works differently because the body does not produce its own antibodies. Instead, antibodies are given directly from an outside source. In the flu, this often involves monoclonal or polyclonal antibody therapies. These lab-made antibodies are designed to target specific parts of the virus and can provide immediate protection. This is especially helpful for people who are already infected or are at high risk for severe illness. For example, antibody-based treatments can be used during outbreaks or pandemics to quickly reduce the severity of disease (Sparrow et al., 2016). Because vaccines can take months to develop and distribute, passive immunity can help fill that gap by providing faster protection during emergencies.

Research also shows that monoclonal antibodies can directly interfere with how the flu virus infects cells. These antibodies can neutralize the virus, block it from entering cells, or even help destroy infected cells (Rudraraju & Subbarao, 2018). In addition, antibody therapies can be used both to prevent infection and to treat it after exposure, making them very flexible in medical settings. Other studies explain that antibody-based treatments are especially useful for high-risk populations, such as older adults or people with weakened immune systems, who may not respond as well to vaccines (Berry, 2017).

Even though passive immunity works quickly, it does not last very long. This is because the body is not producing its own immune response or forming memory cells. Once the antibodies break down over time, the protection disappears. This is one of the biggest limitations of passive immunity. In contrast, active immunity provides longer-lasting protection because it trains the immune system to recognize and fight the virus in the future. Studies on flu immunity also show that antibodies targeting different viral proteins, such as neuraminidase, can contribute to protection, whether they are produced naturally or given through treatment (Eichelberger & Wan, 2024).

Overall, both active and passive immunity are important for protecting against the flu, but they serve different purposes. Active immunity, mainly through vaccination, helps the body build long-term protection by producing its own antibodies and memory cells. Passive immunity provides immediate, short-term protection by supplying ready-made antibodies from an external source. Each type of immunity has its own strengths and weaknesses, but together they play a critical role in reducing the spread and severity of the flu. Understanding these differences not only helps explain how the immune system works but also shows why both vaccines and antibody therapies are necessary in modern medicine.

References

Zhang, X., & Ross, T. M. (2024). Anti-neuraminidase immunity in the combat against influenza. Expert review of vaccines, 23(1), 474–484. https://doi.org/10.1080/14760584.2024.2343689

Berry C. M. (2018). Antibody immunoprophylaxis and immunotherapy for influenza virus infection: Utilization of monoclonal or polyclonal antibodies?. Human vaccines & immunotherapeutics, 14(3), 796–799. https://doi.org/10.1080/21645515.2017.1363135

Li, M., Guo, P., Song, H. et al. Development of universal influenza vaccines: strategies for broadly cross-reactive influenza vaccine responses. Animal Diseases 5, 33 (2025). https://doi.org/10.1186/s44149-025-00187-6

Reber, A., & Katz, J. (2013). Immunological assessment of influenza vaccines and immune correlates of protection. Expert review of vaccines, 12(5), 519–536. https://doi.org/10.1586/erv.13.35

Wall, D. J., Patel, M. M., Chung, J. R., Lee, B., & Dawood, F. S. (2021). Antibody Response and Protection After Receipt of Inactivated Influenza Vaccine: A Systematic Review. Pediatrics, 147(6), e2020019901. https://doi.org/10.1542/peds.2020-019901

Sparrow, E., Friede, M., Sheikh, M., Torvaldsen, S., & Newall, A. T. (2016). Passive immunization for influenza through antibody therapies, a review of the pipeline, challenges and potential applications. Vaccine, 34(45), 5442–5448. https://doi.org/10.1016/j.vaccine.2016.08.057

Rudraraju, R., & Subbarao, K. (2018). Passive immunization with influenza haemagglutinin specific monoclonal antibodies. Human vaccines & immunotherapeutics, 14(11), 2728–2736. https://doi.org/10.1080/21645515.2018.1489947



Fighting the Flu (Poem)

The flu arrives like a winter wind,
a thief that slips beneath the skin,
no loud alarm, no warning bell,
just quiet chaos it begins to tell.

But deep inside the body’s gate,
an army learns, it doesn’t wait,
it studies shadows, shape and name,
then builds a fire to match the flame.

A vaccine comes, a practiced guide,
a harmless “ghost,” the cells decide,
a memory carved in silent code,
a map for every viral road.

And when the real storm comes to call,
the body rises, stands up tall,
with antibodies, sharp and fast,
it knows this enemy from the past.

But sometimes battle must begin
before that memory is within,
so borrowed guards are sent ahead,
with borrowed strength and borrowed thread.

These passive soldiers, quick to fight,
like borrowed stars that cut through the night,
they block the virus, hold the line,
but fade away with passing time.

No memory lives within their hand,
they guard, but do not understand,
they fight the war, then drift away,
not built to stay, not built to stay.

So one path learns, and one path lends,
one builds a future, one defends,
and both together, side by side,
help human bodies stay alive.